«Jejunum

Below is an extended Jejunum patents listing. Click here to return to the Jejunum main in depth entry.

Patents :
US Patent No.	Title
7368279	Three dimensional bioengineered smooth muscle tissue and sphincters and methods therefor
7393927	Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
7393938	Use of lipid conjugates in the treatment of diseases
7393942	Nucleic acids encoding mutant forms of Fas ligand
7393958	Triamide-substituted heterobicyclic compounds
7396809	Methods and reagents for treating glucose metabolic disorders
7396919	Charge reversal of polyion complexes
7399461	Prostate-specific membrane antigen and uses thereof
7399821	Alkylated poly(allylamine) polymers and methods of use
7399823	Antimicrobial theta defensins and methods of using same
7401722	Circular surgical stapler with a detachable anvil
7393534	Compositions and methods for immunotherapy of cancer and infectious diseases
7393525	Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
7390791	Prodrugs of phosphonate nucleotide analogues
7368554	Polynucleotides encoding BSL2v1c2-Ig
7368573	Triamide-substituted heterobicyclic compounds
7375080	Immobilized lactoferrin (Im-LF) antimicrobial agents and uses thereof
7381522	Non-endogenous, constitutively activated known G protein-coupled receptors
7381716	Nanoparticles for protein drug delivery
7384624	Oral contrast and method of producing the oral contrast
7384628	Lactic acid bacteria and its use in direct-fed microbials
7385026	Modified ghrelin polypeptides
7388076	Human immunosuppressive protein
7390505	Nanoparticulate topiramate formulations
7402401	Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof
7402569	Treatment of Helicobacter with isothiocyanates
7422758	Sustained release vitamin composition
7422887	Phospholipase A.sub.2 and gene thereof
7423019	Agent for inducing conversion of intestinal cells into insulin-producing cells and antidiabetic drug
7425217	System and method for inhibiting cellular proliferation with tachykinins
7425579	Methods for inhibiting activity of polyamine transporters
7425624	Sulfotransferase 1A3 sequence variants
7426440	Repair and protection factor scoring method for bioactive agents
7427391	Formulations for use in medical and diagnostic procedures
7427600	Active agent delivery systems and methods for protecting and administering active agents
7429394	Ion binding compositions
7419794	Antibodies specific for CYP1B1
7419479	Catheter
7417022	Compounds and compositions for delivering active agents
7402659	Thymic stromal lymphopoietin receptor molecules and uses thereof
7402663	Modified peptide
7404951	Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
7405238	Pharmacological inducement of the fed mode for enhanced drug administration to the stomach
7407952	Reverse-turn mimetics and compositions and methods related thereto
7410949	Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
7410985	Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
7411048	Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids
7414122	Nucleic acids encoding B7-Like molecules and uses thereof
7416528	Latching device for gastric band
7429595	Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.